Friday, August 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Bitcoin

Strategy Stock: Amplifying Bitcoin’s Movements Through Strategic Leverage

SiterGedge by SiterGedge
March 18, 2026
in Bitcoin, Crypto Stocks, Trading & Momentum
0
Strategy Stock
0
SHARES
31
VIEWS
Share on FacebookShare on Twitter

The shares of Strategy have recently demonstrated a surge that outpaces even the substantial gains seen in Bitcoin itself. Since hitting a low in February, the company’s stock has advanced by approximately 41.6%, starkly outperforming Bitcoin’s 18.3% rise over the same period. This dynamic highlights the effective, though complex, leverage the equity currently provides on the cryptocurrency.

A Multi-Billion Dollar Accumulation

This performance is underpinned by a deliberate and sizable capital allocation. In a concentrated acquisition spree between March 9 and 15, 2026, Strategy purchased Bitcoin valued at $1.57 billion. The funding for this substantial buy was secured through capital measures totaling around $1.6 billion. This included $1.2 billion raised via the STRC series of preferred shares and an additional $400 million from the issuance of new common stock.

As a result of these purchases, Strategy’s total holdings have climbed to 761,068 BTC. This formidable position now represents over 3.5% of the entire circulating supply of Bitcoin.

Should investors sell immediately? Or is it worth buying Strategy?

The Double-Edged Sword of Leverage

The company’s approach, as consistently communicated by Executive Chairman Michael Saylor, is designed to amplify Bitcoin’s volatility. The recent performance ratio of roughly 2.27 to 1 exemplifies this: for every single percentage point gain in Bitcoin, Strategy’s equity increased by more than double that amount.

However, this leveraging mechanism carries inherent risks and can be sensitive to internal capital operations. An event in March illustrated this fragility. The company temporarily halted its Bitcoin purchases funded through the STRC preferred share instrument around the ex-dividend date of March 13. The stock’s price movement responded promptly to this interruption in the capital flow.

Furthermore, investors betting on this leverage are exposed not only to Bitcoin’s price risk but also to potential dilution from the issuance of new common shares, which alters the capital structure. Despite its recent recovery, the share price currently trades approximately 41% below its 52-week high of €391.80, underscoring the heightened volatility involved.

Ad

Strategy Stock: Buy or Sell?! New Strategy Analysis from August 7 delivers the answer:

The latest Strategy figures speak for themselves: Urgent action needed for Strategy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 7.

Strategy: Buy or sell? Read more here...

Tags: Strategy
SiterGedge

SiterGedge

Related Posts

Microsoft Stock
AI & Quantum Computing

Microsoft’s AI Bet Is Paying Off — But the Technicals and the Lawyers Are Closing In

August 7, 2026
Applovin Stock
Earnings

AppLovin Shares Sink as Q3 Guidance Overshadows Another Strong Quarter

August 6, 2026
Kioxia Stock
Asian Markets

Kioxia’s Autumn Crossroads: A Split, a Buyback, and a Market Demanding Answers

August 6, 2026
Next Post
Alphabet Stock

The Power Behind the AI: Alphabet's Massive Infrastructure Push

Krystal Biotech Stock

Krystal Biotech's Global Ambitions: From Vyjuvek Launch to Pipeline Catalysts

Neutra Stock

Shifting Focus: How Neutra is Pivoting to Clinical Trial Management

Recommended

Palantir Stock

Palantir Shares Face Valuation Pressures Despite Strong Earnings

9 months ago
BridgeBio Pharma Stock

BridgeBio Pharma Investors Await Critical Heart Drug Data

9 months ago
Ocugen Stock

Ocugen’s Fresh $130M Cushion Sets the Stage for a Data-Heavy July and a Pivotal Regulatory Filing

1 month ago
Airbnb Stock

Navigating Regulatory Headwinds and Innovation: Airbnb’s Strategic Crossroads

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

MSCI World ETF: Index Provider Rewrites the Rulebook for Fast-Moving Stocks

Airbus’ Paradox: A Slightly Smaller Forecast That Nobody Seems to Mind

Almonty Industries Rebounds From Index-Driven Exit as Tungsten Calculus Shifts Westward

OHB’s Two-Faced Half-Year: Record Orders Mask a Profit Squeeze That Spooked the Market

Trending

Nel ASA Stock
Analysis

Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding

by Jackson Burston
August 7, 2026
0

The Norwegian electrolyser maker Nel ASA is living a split-screen reality. Its order intake just exploded by...

SANDISK Stock

SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market

August 7, 2026
Bitcoin Stock

Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

August 7, 2026
Kioxia Stock

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

August 7, 2026
FALLBACK Stock

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

August 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding
  • SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market
  • Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com